Clinical Trial Update: Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 1/2 study of BMF-219 in healthy adults and in adults with Type 2 Diabetes Mellitus, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BMF-219 (covalent menin inhibitor)

Snippet

Sponsor: Biomea Fusion Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED